Biogen shares soar on landmark Alzheimer's data
Biogen shares soar on landmark Alzheimer's data
September 28, 2022
Shares of Biogen soared more than 40% after a surprise successful trial of its experimental Alzheimer's drug.
Post A Comment:
0 comments:
Leave a comment. Thanks!